481 related articles for article (PubMed ID: 36810086)
1. SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.
Andrades A; Peinado P; Alvarez-Perez JC; Sanjuan-Hidalgo J; García DJ; Arenas AM; Matia-González AM; Medina PP
Mol Cancer; 2023 Feb; 22(1):39. PubMed ID: 36810086
[TBL] [Abstract][Full Text] [Related]
2. BAFfling pathologies: Alterations of BAF complexes in cancer.
Arnaud O; Le Loarer F; Tirode F
Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
[TBL] [Abstract][Full Text] [Related]
3. BCL7A and BCL7B potentiate SWI/SNF-complex-mediated chromatin accessibility to regulate gene expression and vegetative phase transition in plants.
Lei Y; Yu Y; Fu W; Zhu T; Wu C; Zhang Z; Yu Z; Song X; Xu J; Liang Z; Lü P; Li C
Nat Commun; 2024 Jan; 15(1):935. PubMed ID: 38296999
[TBL] [Abstract][Full Text] [Related]
4. The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
Nguyen VT; Tessema M; Weissman BE
Cancer Treat Res; 2023; 190():211-244. PubMed ID: 38113003
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K
Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044
[TBL] [Abstract][Full Text] [Related]
6. SWI/SNF chromatin remodeling and human malignancies.
Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
[TBL] [Abstract][Full Text] [Related]
7. A rationale to target the SWI/SNF complex for cancer therapy.
Hohmann AF; Vakoc CR
Trends Genet; 2014 Aug; 30(8):356-63. PubMed ID: 24932742
[TBL] [Abstract][Full Text] [Related]
8. Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.
Wanior M; Krämer A; Knapp S; Joerger AC
Oncogene; 2021 May; 40(21):3637-3654. PubMed ID: 33941852
[TBL] [Abstract][Full Text] [Related]
9. Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.
Shain AH; Giacomini CP; Matsukuma K; Karikari CA; Bashyam MD; Hidalgo M; Maitra A; Pollack JR
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):E252-9. PubMed ID: 22233809
[TBL] [Abstract][Full Text] [Related]
10. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.
Baliñas-Gavira C; Rodríguez MI; Andrades A; Cuadros M; Álvarez-Pérez JC; Álvarez-Prado ÁF; de Yébenes VG; Sánchez-Hernández S; Fernández-Vigo E; Muñoz J; Martín F; Ramiro AR; Martínez-Climent JA; Medina PP
Leukemia; 2020 Oct; 34(10):2722-2735. PubMed ID: 32576963
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.
Zhang Z; Li Q; Sun S; Li Z; Cui ZG; Zhang M; Liu Q; Zhang Y; Xiong S; Zhang S
World J Surg Oncol; 2022 Dec; 20(1):383. PubMed ID: 36464671
[TBL] [Abstract][Full Text] [Related]
13. Bromodomain-containing proteins BRD1, BRD2, and BRD13 are core subunits of SWI/SNF complexes and vital for their genomic targeting in Arabidopsis.
Yu Y; Fu W; Xu J; Lei Y; Song X; Liang Z; Zhu T; Liang Y; Hao Y; Yuan L; Li C
Mol Plant; 2021 Jun; 14(6):888-904. PubMed ID: 33771698
[TBL] [Abstract][Full Text] [Related]
14. SWI/SNF Infobase-An exclusive information portal for SWI/SNF remodeling complex subunits.
Mani U; S AS; Goutham R N A; Mohan S S
PLoS One; 2017; 12(9):e0184445. PubMed ID: 28961249
[TBL] [Abstract][Full Text] [Related]
15. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
[TBL] [Abstract][Full Text] [Related]
16. Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas.
Ahadi MS; Fuchs TL; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
Histopathology; 2022 May; 80(6):906-921. PubMed ID: 34951482
[TBL] [Abstract][Full Text] [Related]
17. Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancers.
Sasaki M; Ogiwara H
Cancer Sci; 2020 Mar; 111(3):774-782. PubMed ID: 31955490
[TBL] [Abstract][Full Text] [Related]
18. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
Kadoch C; Hargreaves DC; Hodges C; Elias L; Ho L; Ranish J; Crabtree GR
Nat Genet; 2013 Jun; 45(6):592-601. PubMed ID: 23644491
[TBL] [Abstract][Full Text] [Related]
19. Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation.
Marquez SB; Thompson KW; Lu L; Reisman D
Front Oncol; 2014; 4():372. PubMed ID: 25774356
[TBL] [Abstract][Full Text] [Related]
20. Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
Chabanon RM; Morel D; Postel-Vinay S
Semin Cancer Biol; 2020 Apr; 61():180-198. PubMed ID: 31568814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
